Introducing the TurboCHO™ Protein Expression Kit, a launchpad in every kit. Producing research-grade antibodies and proteins is a foundational step in drug discovery and biologics development. The new ...
New kit offers researchers and development teams a meaningful advance in expression speed and output BOSTON, May 12, 2026 /PRNewswire/ -- GenScript Biotech Corporation announced the launch of ...
Regenxbio’s gene therapy for Duchenne muscular dystrophy has smashed the primary endpoint of its pivotal trial, securing a ...
LenioBio GmbH, a TechBio company commercializing its ALiCE cell-free protein expression platform, today announced a collaborative agreement with Twist Bioscience Corporation. The collaboration will in ...
CMP-002 administration resulted in a statistically significant improvement in seizure phenotypes and parameters in a SYNGAP1 haploinsufficient mouse model ...
Tevard Biosciences, Inc., a biotechnology company pioneering tRNA-based therapies to cure a broad range of genetic diseases, ...
ParcelBio, a biotechnology company developing a new class of potent and durable mRNA medicines, today announced it has raised ...
Phase 1 clinical data in patients with Parkinson’s disease demonstrating reduction in endolysosomal and neuroinflammatory biomarkers implicated in Parkinson’s disease and progressive supranuclear ...
Optimized additive selection could help yeast-based cell-free protein expression systems fulfill their potential at commercial scale.
Stem cells are the original cell type from which all other cells and tissues in the body develop through a very tightly regulated process. However, how stem cells differentiate in addition to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results